Bristol-Myers Squibb Company operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bristol-Myers Squibb Company with three other
companies in this sector in the United States:
sales of $20.85 billion
of which 33%
Eli Lilly and Company
of which 38%
was Endocrinology), and
Teva Pharmaceutical Industries Limited
of which 55%
was Generic Madicines).
During the year ended December of 2016, sales at
Bristol-Myers Squibb Company were $19.43 billion.
increase of 17.3%
versus 2015, when the company's sales were $16.56 billion.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Bristol-Myers Squibb Company had sales
of $21.24 billion.